1 / 18

April 23, 2013

Clinical Characteristics and Outcomes of Elderly Patients Treated With ICD and CRTD in Real World Setting: Data From the Israeli ICD Registry . M. Suleiman, M. Haim, JE. Schliamser, M. Boulos, S. Viskin, M. Swissa, N. Gavrielov-Yusim, T. Fuchs, M. Ilan, I. Goldenberg6, and M. Glikson6.

aadi
Télécharger la présentation

April 23, 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Characteristics and Outcomes of Elderly Patients Treated With ICD and CRTD in Real World Setting: Data From the Israeli ICD Registry M. Suleiman, M. Haim, JE. Schliamser, M. Boulos, S. Viskin, M. Swissa, N. Gavrielov-Yusim, T. Fuchs, M. Ilan, I. Goldenberg6, and M. Glikson6 April 23, 2013

  2. Background • Elderly patients (eg, age ≥75 or 80 years) and patients with major co-morbidities were excluded from some of the major ICD/CRTD trials, and few patients over age 75 were enrolled in any of the trials • It is not known, therefore, what survival benefit elderly patients derive from device-based therapy

  3. Purpose To evaluate, the outcomes of elderly patients who received device-based therapy (ICD or CRT-D) in a “real-world” scenario

  4. Methods • Israeli ICD Registry Database • Period: Jul 2010-June 2012 • Study end points • Death • Appropriate ICD therapies for VA • Readmission to hospital for HF • The combined endpoints of HF or death, VA or death • Need for device related surgical re-intervention.

  5. Baseline Characteristics

  6. Baseline Characteristics (cont’)

  7. Baseline Characteristics (cont’)

  8. Device implanted Indication P<0.001 P<0.001

  9. Outcomes • 1218 (84% male; age≤65, n=612; 66-75, n=376; >75, n=230) unselected registry patients were prospectively followed for the occurrence of clinical outcomes.

  10. Death o HF in the General Population

  11. Death or HF According to Device Type In ICD recipients In RCTD recipients

  12. Death or VA in the General Population

  13. Device-Related Complications Aassociatedwith Surgical Re-interventions

  14. Multivariate analysis: Risk of HF/Death by age category (reference group =age<65)

  15. Multivariate analysis: Risk of VA/Death by age category (reference group =age<65)

  16. Main Findings • Of new ICDs and CRTDs implanted in Israel, >50% are in patients >65 yo and >20% in patients >75 yo • Elderly patients • have higher risk profile • more likely to receive CRTD device • > secondary prevention indication

  17. Main Findings • Our data add to and support the existing evidence from previous studies that the association between advanced age and adverse clinical outcomes is attenuated in elderly patients implanted with CRT-D devices.

  18. Main Findings • Elderly patients implanted with ICDs experienced a significant increase in the cumulative probability of the combined end-points of appropriate ICD therapy or death and HF or death • In contrast, the risk of both HF and arrhythmic outcomes was attenuated among elderly patients implanted with CRT-D devices.

More Related